Back
Compare AU
Compare DRUG vs. IHHY
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares Global Healthcare Currency Hedged ETF (DRUG) and the iShares Global High Yield Bond (Aud Hedged) ETF (IHHY). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | IHHY | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 74 | 8 |
Median incremental investment | $735.27 | $1,893.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,083.20 | $1,880.76 |
Average age group | > 35 | 26 - 35 |
Key Summary
DRUG | IHHY | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | IHHY.AX was created on 2015-12-04 by iShares. The fund's investment portfolio concentrates primarily on high yield fixed income. The Fund aims to provide investors with the performance of an index, before fees and expenses (including the cost of hedging), composed of liquid, global developed, high yield corporate bonds (hedged to Australian dollars). |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) BRL - BRAZILIAN REAL (0 %) | ISH GLBL HY CP BD UCITS USD DIST (96.03 %) USD/AUD (2.62 %) EUR/AUD (1.28 %) |
Top 3 industries | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) | Other (93.76 %) Communication Services (0.00 %) |
Top 3 countries | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) | United States (4.68 %) |
Management fee | 0.57 % | 0.56 % |
Key Summary
DRUG | IHHY | |
|---|---|---|
Issuer | BetaShares | iShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | Markit iBoxx Global Developed Markets High Yield Capped Hedged to AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.56 % |
Price | $9.30 | $89.56 |
Size | $174.867 million | $247.780 million |
10Y return | 97.87 % | -16.01 % |
Annual distribution yield (5Y) | 1.82 % | 5.27 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 09/12/2015 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | IHHY | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 74 | 8 |
Median incremental investment | $735.27 | $1,893.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,083.20 | $1,880.76 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
DRUG | IHHY | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | IHHY |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |